Edition:
United Kingdom

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

30.28USD
14 Dec 2017
Change (% chg)

$-0.54 (-1.75%)
Prev Close
$30.82
Open
$30.90
Day's High
$31.65
Day's Low
$29.96
Volume
211,160
Avg. Vol
173,446
52-wk High
$32.17
52-wk Low
$11.30

Select another date:

Tue, Dec 5 2017

BRIEF-Arena Pharma, Everest Medicines Enter Into Development And Commercialization Partnership For Ralinepag And Etrasimod In China

* ARENA PHARMACEUTICALS AND EVEREST MEDICINES ENTER INTO DEVELOPMENT AND COMMERCIALIZATION PARTNERSHIP FOR RALINEPAG AND ETRASIMOD IN CHINA

BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.86

* Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results

BRIEF-Arena Pharmaceuticals Q2 loss per share $0.77

* Arena Pharmaceuticals provides corporate update and reports second quarter 2017 financial results

BRIEF-Arena Pharmaceuticals says public offering of 6.25 mln common shares priced at $24 per share

* Arena Pharmaceuticals announces pricing of public offering of common stock

BRIEF-Arena Pharmaceuticals announces proposed public offering of common stock

* Arena Pharmaceuticals announces proposed public offering of common stock

Arena's heart-lung drug succeeds in mid-stage study, shares soar

U.S. drug developer Arena Pharmaceuticals Inc said on Monday its experimental drug for pulmonary arterial hypertension (PAH), a rare but deadly lung disease, met the main goal in a mid-stage study.

BRIEF-Arena Pharmaceuticals Inc's board increased size of board from nine directors to ten directors

* Arena Pharmaceuticals Inc - on June 13, 2017, board of directors increased size of board from nine directors to ten directors Source text:(http://bit.ly/2rAYXbA) Further company coverage:

Select another date: